Thermo Fisher expects stronger Q4

 

• Thermo Fisher (TMO +1.3%) sees FY adjusted EPS of $19.17, beating consensus estimate $18.32, representing growth of 55% over 2019, compared to the original expected growth of 48% provided on October 21.
• Forecasts Q4 organic revenue growth 40%, compared to original expectation of 29%, driven by increased levels of organic growth in both the base business and COVID-19 response revenue.
• https://seekingalpha.com/news/3640532-thermo-fisher-expects-stronger-fourth-quarter